Sign in
4

Changes in Ownership

SPRUCE BIOSCIENCES, INC. Filed Acc 0001415889-25-020265

Options or other derivatives

  • Interim Chief Medical Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ways Kirk Interim Chief Medical Officer 2025-07-23 Grant or award · Stock Option (Right to Buy) +30,000 30,000 D
Loading xslF345X05/form4-07242025_110718.xml…